Completed PHASE3 INTERVENTIONAL 2-arm NCT01800942

Prevention of Bacterial Infections in Newborn (PregnAnZI)

Prevention of Bacterial Infections in the Newborn by Pre-delivery Administration of Azithromycin (AZI): a Placebo-controlled Randomized Trial

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Neonatal Infection

Interventions Azithromycin and Placebo

Updated 8 times since 2017 Last updated: Mar 20, 2018 Started: Feb 28, 2013 Primary completion: Dec 31, 2014 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Neonatal Infection and is currently completed. London School of Hygiene and Tropical Medicine leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Apr 2018 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Apr 2018 [monthly]

Completed PHASE3

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fajara, The Gambia